Small molecule modulators of pantothenate kinases
US11891378B2 · kind B2 · utility
0Cited by
5References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 26, 2018 |
| Grant date | Feb 6, 2024 |
| Priority date | — |
| Expiry date | Dec 26, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/197
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders (such as diabetes mellitus type II), neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.